Frank Pun

Frank Pun's work experience includes being the Head of Hong Kong Office at Insilico Medicine starting in September 2022, an Associate Director at Insilico Medicine from July 2021 to August 2022, and a Project & Operations Manager at Insilico Medicine from September 2020 to June 2021. Frank also served as the Chief Executive Officer at PharmacoGenetics Limited from February 2019 to August 2020, and as the Founder & Director at Everest Holding Limited from April 2012 to January 2019. Prior to that, they were a Visiting Scholar & Research Associate at The Hong Kong University of Science and Technology from March 2010 to March 2012.

Frank Pun attended The Hong Kong University of Science and Technology from 2001 to 2004, where they earned a Bachelor of Science degree in Biochemistry. Frank then pursued further education at the same institution, completing their Doctor of Philosophy degree in Biochemistry from 2004 to 2010. Finally, Frank Pun attended Rutgers Business School from 2015 to 2018, obtaining a Master of Business Administration (MBA) degree.